Lonza | chemanager-online.com - Chemistry and Life Science

Jan. 31, 2019
News & Opinions
Funk to Follow Ridinger as Lonza CEO
Richard Ridinger, CEO of Basel, Switzerland-based fine chemicals producer Lonza since April 2012, will retire at the end of February and be succeeded on Mar. 1 by Marc Funk, current chief operating officer of the company’s Pharma ...
Dec. 12, 2018
News & Opinions
Lonza and GE Healthcare in China Biopharma Pact
Swiss-based Lonza is working with GE Healthcare, a General Electric subsidiary, to establish a biologics facility in Guangzhou, China. The deal will give Lonza a strategic base in China to respond to the country’s growing demand for ...
Nov. 20, 2018
News & Opinions
Sartorius Stedim and Lonza Modify Supply Pact
Biopharmaceutical supplier Sartorius Stedim Biotech and fine chemicals producer Lonza are modifying their 2012 agreement for supply of cell culture media, which gave SSB exclusive sales and marketing rights for certain media and buffers ...
Nov. 02, 2018
News & Opinions
DCAT Announces New Board of Directors
Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: Stephan Kutzer, ...
Nov. 02, 2018
News & Opinions
Lonza to Sell Water Care to Platinum Equity
Lonza has agreed to sell its Water Care business to US investment group Platinum Equity for $630 million, while still discussing the inclusion of the company’s business in France. The deal is expected to close in the first ...
Oct. 04, 2018
News & Opinions
Lonza and Clovis Open New Monoplant for Ovarian Cancer Drug
Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug for several ovarian cancer indications. Clovis ...
Oct. 03, 2018
Topics
M&A in Pharma and CRO/CMO Industry
Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself. The recent acquisitions of Capsugel by Lonza and of ...
Sep. 21, 2018
Topics
A Wide Spectrum of Contract Services
With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service models that provide both active pharmaceutical ingredient ...
Sep. 19, 2018
Topics
Supply Security of Non-cGMP Materials
The topic of supply chain security is not a new one for the pharmaceutical industry, and much of that discussion has been dominated by the cGMP portion of the API supply chain. The discussion regularly addresses reduction of risk, superior ...
Apr. 17, 2018
News & Opinions
Lonza Dedicates US Gene Therapy Center
Swiss fine chemicals producer and pharmaceutical industry supplier Lonza has opened what it said is the world's largest dedicated cell and gene therapy center at Pearland, near Houston, in the US state of Texas.

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag